Also known as Ninlaro.
chemXplore tracks 1 project producing ixazomib.
The new facility will expand Takeda's Grange Castle site, creating 40 jobs and producing NINLARO® for global markets. Construction starts June 2017, with operations beginning in late 2018.
The €40M investment will expand the Grange Castle site, creating 40 jobs and producing the oncology product NINLARO™. Supported by IDA Ireland, it highlights confidence in Ireland's pharma sector.
A subscription lists every plant we track for ixazomib, with its owners and capacity. What a subscription does →
